| 書(shū)目名稱(chēng) | Non-Biological Complex Drugs |
| 副標(biāo)題 | The Science and the |
| 編輯 | Daan J.A. Crommelin,Jon S. B. de Vlieger |
| 視頻video | http://file.papertrans.cn/667/666856/666856.mp4 |
| 概述 | Discusses the challenges of developing NBCDs, recognizing the special position of these products in the regulatory landscape.Reviews analytical tools, pharmacology and PK/PD.Valuable resource for orig |
| 叢書(shū)名稱(chēng) | AAPS Advances in the Pharmaceutical Sciences Series |
| 圖書(shū)封面 |  |
| 描述 | .The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests..This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table. . |
| 出版日期 | Book 2015 |
| 關(guān)鍵詞 | Iron carbohydrate complexes; Liposomes; albumin-cytostatic complexes; glatiramoids; nanomedicines; nanosi |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-16241-6 |
| isbn_softcover | 978-3-319-35851-2 |
| isbn_ebook | 978-3-319-16241-6Series ISSN 2210-7371 Series E-ISSN 2210-738X |
| issn_series | 2210-7371 |
| copyright | Springer International Publishing Switzerland 2015 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-20 18:56
發(fā)表于 2025-3-21 19:32:32
